Order Article Reprints

Shin JW, Kim S, Ha S, Choi B, Kim S, Im S-A, Yoon T-Y, Chung J. The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab. Biomolecules. 2019; 9(10):629. https://doi.org/10.3390/biom9100629

Shin, Jung Won, Soohyun Kim, Suji Ha, Byungsan Choi, Seongyeong Kim, Seock-Ah Im, Tae-Young Yoon, and Junho Chung. 2019. "The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab" Biomolecules 9, no. 10: 629. https://doi.org/10.3390/biom9100629

Shin, J. W., Kim, S., Ha, S., Choi, B., Kim, S., Im, S.-A., Yoon, T.-Y., & Chung, J. (2019). The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab. Biomolecules, 9(10), 629. https://doi.org/10.3390/biom9100629